Opinion|Videos|November 19, 2025

Enhancing Support and Care Coordination in mCRC

Panelists discuss how support networks and coordinated care are essential for delivering third-line metastatic colorectal cancer therapies effectively in the community.

Panelists stress the importance of support structures, including guidance from academic institutions, professional networks, and patient advocacy groups, in expanding access to third-line therapies.

They note that effective coordination among oncologists, pharmacists, and other providers is vital to ensure safe and seamless care transitions for patients.

This collaborative approach helps optimize patient outcomes while reducing barriers to therapy initiation and adherence.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.


Latest CME

Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo